Khảo sát tỷ lệ, đặc điểm hẹp động mạch vành trên MSCT tim trên 73 bệnh nhân đái tháo đường type 2 có biến chứng suy thận mạn giai đoạn cuối điều trị tại bệnh viện Trưng Vương từ 3/2011 đến 4/2105. Kết quả cho thấy tỷ lệ hẹp lòng động mạch vành là 79,5%. Có sự khác biệt về số nhánh. số đoạn, vị trí nhánh hẹp động mạch vành ở nhóm bệnh nhân có tiểu đường type 2 so với nhóm chứng. Thời gian suy thận mạn trên 2 năm làm gia tăng hẹp động mạch vành ở bệnh nhân tiểu đường có tuy thận mạn giai đoạn cuối.Objective: The survey of the rate and characteristics of the coronary arteries stenosis by using cardiac MSCT mdiabetie patients who have the end-stage of the chronic kidney disease. Subjects and methods: cross-sectional description, comparison of 73 diabebeend-stage kidney disease patients (diabetic group) and 68 end-stage kidney disease patients causing by others (control group). All patients were cllnicallyexamined and meansured serum phosphor, PTH levels. Cardiac MSCT was performed for all patients. Result: The rate of significant coronary arteries stenosis in diabetic group was significant higher than in control group (79.5% versus 26.8%
p<
0.05). Mean of stenosed branches, segments of coronary arteries in diabetic group is not significantly higher than in control group (branch: 1.78 ± 0.87 versus 1.39 ± 0.61
segment: 3.00 ± 1.95 versus 2.33±2.00
p>
0.05). The rate of mulbstenosed branches in diabetic group is not significantly higher than in control group (52.5% versus 33.4%
p >
0.05). Age >
60 years, gender, penod of hypertension >
5 years, BMI >
23, elevated phosphor and PTH were not association between the proportion of patients have the significant stenosed coronary arteries in diabetic group but period of renal failure >
2 years was significantly effected to them (OR = 3.6, p<
0,05). Conclusion: The rate of significant stenosed coronary arterieswas significant higher in diabetic end-stage kidney disease patients. Characteristics of coronary arteries stenosis in diabetic end-stage kidney disease pabents was not significantly different from end-stage kidney disease patients causing by others.